Brief: Cleveland Biolabs Says Entered Into Agreement For Sale Of 1.5 Mln Shares
01/06/2020 18:58
June 1 (Reuters) - Cleveland Biolabs Inc CBLI.O :
* CLEVELAND BIOLABS - ENTERED INTO AGREEMENT FOR ISSUANCE
AND SALE
OF 1.5 MILLION SHARES OF COMMON STOCK AT $2.0945 PER SHARE
Source text for Eikon: urn:newsml:reuters.com:*:nNDL1vDCW2
Further company coverage: CBLI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Statera Biopharma
See all news20/20 Biolabs jumps on Ebola, hantavirus testing plans
Tivic Health Systems rises after deal for late-stage immunotherapy drug
Brief: Tivic Health Acquires Exclusive Worldwide Rights To Phase III TLR5 Agonist
Brief: Statera Biopharma Inc Quarterly Loss Per Share $0.20
Brief: Statera Biopharma Inc - On October 12, 2022, Co Entered A Binding Memorandum Of Understanding (“MoU”) With Holobeam Technologies, Inc